Pathophysiology of Resistant Hypertension: The Role of Sympathetic Nervous System

被引:91
作者
Tsioufis, Costas [1 ]
Kordalis, Athanasios [1 ]
Flessas, Dimitris [1 ]
Anastasopoulos, Ioannis [1 ]
Tsiachris, Dimitris [1 ]
Papademetriou, Vasilios [1 ]
Stefanadis, Christodoulos [1 ]
机构
[1] Univ Athens, Hippokrat Hosp, First Cardiol Clin, 3 Kolokotroni St, Athens 15236, Greece
关键词
D O I
10.4061/2011/642416
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Resistant hypertension (RH) is a powerful risk factor for cardiovascular morbidity and mortality. Among the characteristics of patients with RH, obesity, obstructive sleep apnea, and aldosterone excess are covering a great area of the mosaic of RH phenotype. Increased sympathetic nervous system (SNS) activity is present in all these underlying conditions, supporting its crucial role in the pathophysiology of antihypertensive treatment resistance. Current clinical and experimental knowledge points towards an impact of several factors on SNS activation, namely, insulin resistance, adipokines, endothelial dysfunction, cyclic intermittent hypoxaemia, aldosterone effects on central nervous system, chemoreceptors, and baroreceptors dysregulation. The further investigation and understanding of the mechanisms leading to SNS activation could reveal novel therapeutic targets and expand our treatment options in the challenging management of RH.
引用
收藏
页数:7
相关论文
共 89 条
[1]   Sympathetic neural activation in visceral obesity [J].
Alvarez, GE ;
Beske, SD ;
Ballard, TP ;
Davy, KP .
CIRCULATION, 2002, 106 (20) :2533-2536
[2]   Subcutaneous obesity is not associated with sympathetic neural activation [J].
Alvarez, GE ;
Ballard, TP ;
Beske, SD ;
Davy, KP .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2004, 287 (01) :H414-H418
[3]   ELEVATED SYMPATHETIC-NERVE ACTIVITY IN BORDERLINE HYPERTENSIVE HUMANS - EVIDENCE FROM DIRECT INTRANEURAL RECORDINGS [J].
ANDERSON, EA ;
SINKEY, CA ;
LAWTON, WJ ;
MARK, AL .
HYPERTENSION, 1989, 14 (02) :177-183
[4]   Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled [J].
Bramlage, P ;
Pittrow, D ;
Wittchen, HU ;
Kirch, W ;
Boehler, S ;
Lehnert, H ;
Hoefler, M ;
Unger, T ;
Sharma, AM .
AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (10) :904-910
[5]   Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea [J].
Calhoun, DA ;
Nishizaka, MK ;
Zaman, MA ;
Harding, SM .
CHEST, 2004, 125 (01) :112-117
[6]   Hyperaldosteronism among with resistant black and white subjects hypertension [J].
Calhoun, DA ;
Nishizaka, MK ;
Zaman, MA ;
Thakkar, RB ;
Weissmann, P .
HYPERTENSION, 2002, 40 (06) :892-896
[7]   Resistant hypertension: Diagnosis, evaluation, and treatment - A Scientific Statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research [J].
Calhoun, David A. ;
Jones, Daniel ;
Textor, Stephen ;
Goff, David C. ;
Murphy, Timothy P. ;
Toto, Robert D. ;
White, Anthony ;
Cushman, William C. ;
White, William ;
Sica, Domenic ;
Ferdinand, Keith ;
Giles, Thomas D. ;
Falkner, Bonita ;
Carey, Robert M. .
HYPERTENSION, 2008, 51 (06) :1403-1419
[8]   AUGMENTED RESTING SYMPATHETIC ACTIVITY IN AWAKE PATIENTS WITH OBSTRUCTIVE SLEEP-APNEA [J].
CARLSON, JT ;
HEDNER, J ;
ELAM, M ;
EJNELL, H ;
SELLGREN, J ;
WALLIN, BG .
CHEST, 1993, 103 (06) :1763-1768
[9]   Short-term fasting-induced autonomic activation and changes in catecholamine levels are not mediated by changes in leptin levels in healthy humans [J].
Chan, Jean L. ;
Mietus, Joseph E. ;
Raciti, Patricia M. ;
Goldberger, Ary L. ;
Mantzoros, Christos S. .
CLINICAL ENDOCRINOLOGY, 2007, 66 (01) :49-57
[10]   Sleep apnoea and sympathetic nervous system activity: A review [J].
Coy, TV ;
Dimsdale, JE ;
AncoliIsrael, S ;
Clausen, J .
JOURNAL OF SLEEP RESEARCH, 1996, 5 (01) :42-50